BMJ Sexual & Reproductive Health

Papers
(The TQCC of BMJ Sexual & Reproductive Health is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Telemedicine medical abortion at home under 12 weeks’ gestation: a prospective observational cohort study during the COVID-19 pandemic53
Disrupted prevention: condom and contraception access and use among young adults during the initial months of the COVID-19 pandemic. An online survey52
Abortion regulation in Europe in the era of COVID-19: a spectrum of policy responses44
The impact of COVID-19 on contraception and abortion care policy and practice: experiences from selected countries42
Contraceptive dynamics during COVID-19 in sub-Saharan Africa: longitudinal evidence from Burkina Faso and Kenya40
Demand for self-managed online telemedicine abortion in eight European countries during the COVID-19 pandemic: a regression discontinuity analysis37
At-home telemedicine for medical abortion in Australia: a qualitative study of patient experiences and recommendations35
Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes30
Impact of the SARS-CoV-2 pandemic on access to contraception and pregnancy intentions: a national prospective cohort study of the UK population23
Abortion attempts without clinical supervision among transgender, nonbinary and gender-expansive people in the United States19
Sexual and reproductive health and attitudes towards sex of young adults in China19
‘Scrambling to figure out what to do’: a mixed method analysis of COVID-19’s impact on sexual and reproductive health and rights in the United States18
Factors associated with female genital mutilation: a systematic review and synthesis of national, regional and community-based studies17
Why women choose abortion through telemedicine outside the formal health sector in Germany: a mixed-methods study17
Age pattern of sexual activities with the most recent partner among men who have sex with men in Melbourne, Australia: a cross-sectional study15
Women’s experiences of self-administration of misoprostol at home as part of early medical abortion: a qualitative evaluation14
Why women choose at-home abortion via teleconsultation in France: drivers of telemedicine abortion during and beyond the COVID-19 pandemic14
Towards individualised contraceptive counselling: clinical and reproductive factors associated with self-reported hormonal contraceptive-induced adverse mood symptoms12
Client perspectives on choice of abortion method in England and Wales12
Time trends in contraceptive prescribing in UK primary care 2000–2018: a repeated cross-sectional study11
Defining counselling in contraceptive information and services: outcomes from an expert think tank10
Access to and quality of sexual and reproductive health services in Britain during the early stages of the COVID-19 pandemic: a qualitative interview study of patient experiences10
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake10
The state of global abortion data: an overview and call to action10
Telemedicine as an alternative way to access abortion in Italy and characteristics of requests during the COVID-19 pandemic10
Access to sexual healthcare during New Zealand’s COVID-19 lockdown: cross-sectional online survey of 15–24-year-olds in a high deprivation region9
A qualitative study of abortion care providers’ perspectives on telemedicine medical abortion provision in the context of COVID-199
Strengthening contraceptive counselling: gaps in knowledge and implementation research9
Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding8
Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-198
Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic8
‘Our COVID-19 cloud silver lining’: the initiation and progress of postnatal contraception services during the COVID-19 pandemic in a UK maternity hospital7
Miles and days until medical abortion via TelAbortion versus clinic in Oregon and Washington, USA7
Making the case for advance provision of mifepristone and misoprostol for abortion in the United States7
Women’s attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review7
Delivering cervical cancer screening during the COVID-19 emergency7
Perceived barriers and facilitators to accessing and utilising sexual and reproductive healthcare for people who experience homelessness: a systematic review7
Physician perspectives of abortion advocacy: findings from a mixed-methods study6
Induced abortion and access to contraception in Sweden during the COVID-19 pandemic6
Postpartum long-acting contraception uptake and service delivery outcomes after a multilevel intervention in Kigali, Rwanda6
FSRH Guideline (March 2023) Intrauterine contraception6
Can an online educational video broaden young women’s contraceptive choice? Outcomes of the PREFER pre-post intervention study6
Disability, sexual and reproductive health: a scoping review of healthcare professionals’ views on their confidence and competence in care provision6
Abortion education in UK medical schools: a survey of medical educators6
What does informal access to misoprostol in Colombia look like? A mystery client methodology in Bogotá and the Coffee Axis6
Three Delays Model applied to prevention of unsafe abortion in Ghana: a qualitative study6
Effect of a narrative intervention on individual-level abortion stigma: a randomised controlled trial5
Oral contraception over the counter at last: a momentous occasion5
An observational study of patient experiences with a direct-to-patient telehealth abortion model in Australia5
Novel use of menstrual blood for monitoring glycaemic control in patients with diabetes: a proof-of-concept study5
Potentials and pitfalls of including pharmacies as youth-friendly contraception providers in low- and middle-income countries5
Introduction of the National Health Service early medical abortion service in Northern Ireland – an emergency response to the COVID-19 pandemic5
Challenges of accessing emergency contraceptive pills in Japan5
Long-acting reversible contraception and satisfaction with structured contraceptive counselling among non-migrant, foreign-born migrant and second-generation migrant women: evidence from a cluster ran5
Maintaining sexual and reproductive health services in the UK during COVID-195
Get PrEPPT (pre-exposure prophylaxis and pregnancy termination): an exploration of the values, attitudes and preferences regarding HIV and PrEP among women seeking abortion5
Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey4
Integrating pre-exposure prophylaxis of HIV infection into family planning services: a scoping review4
Reducing the harms of unsafe abortion: a systematic review of the safety, effectiveness and acceptability of harm reduction counselling for pregnant persons seeking induced abortion4
Blood clots, COVID-19 vaccines and the contraceptive pill: are we heading for a repeat of the 1995 pill scare?4
Short interpregnancy interval: circumstance or choice?4
Making the case for supported self-managed medical abortion as an option for the future4
Preventing first births among adolescents in Mexico City’s public abortion programme4
Accessing abortion outside jurisdiction following legalisation of abortion in the Republic of Ireland4
Immediate versus delayed insertion of the copper intrauterine device after medical abortion at 17–20 gestational weeks: a randomised controlled trial4
Travelling for abortion services in Mexico 2016–2019: community-level contexts of Mexico City public abortion clients4
Dysmenorrhoea as a risk factor for pain with intrauterine device insertion4
Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption4
0.03044605255127